Methods for spermatogonial stem cell (SSC) transfer

Inventors

West, James • MAJKA, Susan M.

Assignees

Acceligen Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-9670458-B2

Patent

Publication Date

2017-06-06

Expiration Date


Abstract

The present invention provides highly advantageous and efficient methods for spermatogonial stem cell (SSC) transfer for the generation of animals having valuable traits or genetic background.

Core Innovation

The invention provides methods for generating fertilization-competent haploid male gametes by using spermatogonial stem cells (SSCs) from a male donor animal and introducing the donor SSCs into a reproductive organ of a recipient animal. The recipient produces donor-derived, fertilization-competent, haploid male gametes, with optional collection of the donor-derived haploid male gametes produced by the recipient.

In one approach, the recipient is a sterile, hybrid male recipient animal having at least one parentage from the same genus as the donor animal. The donor SSCs are introduced into a reproductive organ of the sterile, hybrid male recipient animal that produces donor-derived, fertilization-competent, haploid male gametes, thereby addressing recipient-derived sperm mixtures by promoting donor-derived gamete production.

In another approach, the recipient animal is genetically-modified such that native male gametes produced by the recipient express at least one detectable biomarker label. Donor SSCs are introduced into a reproductive organ of the genetically-modified male recipient that produces donor-derived, fertilization-competent, haploid male gametes; donor-derived gametes are collected that lack the biomarker label, and native male gametes are distinguished from donor-derived male gametes based on the detectable biomarker label.

Claims Coverage

The partial content includes three independent claims. Across these independent claims, there are three main inventive feature sets: donor SSC transfer into a sterile hybrid male recipient that yields donor-derived fertilization-competent haploid male gametes, donor SSC transfer into a genetically-modified recipient with detectable biomarker labeling that enables distinguishing and collecting donor-derived gametes lacking the label, and donor SSC transfer into a sterile genetically-modified recipient with an intact spermatogenic compartment but blocked spermatogenesis through specified gene deletions or inactivating mutations.

Sterile hybrid recipient for donor-derived haploid male gametes

Providing spermatogonial stem cells (SSCs) from a male donor animal; providing a sterile, hybrid male recipient animal with at least one parentage from the same genus as the donor animal; and introducing the donor SSCs into a reproductive organ of the sterile, hybrid male recipient animal that produces donor-derived, fertilization-competent, haploid male gametes; optionally collecting the donor-derived, fertilization-competent, haploid male gametes.

Biomarker-labeled native gametes for distinguishing donor-derived gametes

Providing spermatogonial stem cells (SSCs) from a male donor animal; providing a recipient animal genetically-modified such that native male gametes express at least one detectable biomarker label; and introducing the donor SSCs into a reproductive organ of the genetically-modified male recipient animal that produces donor-derived, fertilization-competent, haploid male gametes; collecting donor-derived, fertilization-competent, haploid male gametes that lack the biomarker label; and distinguishing the native male gametes from the donor-derived male gametes based on the detectable biomarker label.

Sterile genetically-modified recipient with intact spermatogenic compartment

Providing spermatogonial stem cells (SSCs) from a male donor animal; providing a sterile male recipient animal genetically-modified such that the animal has an intact spermatogenic compartment but cannot perform spermatogenesis, wherein the recipient contains a deletion or an inactivating mutation in a gene selected from Deleted-in-Azoospermia like (DAZL); protamine genes associated with DNA packaging in the sperm nucleus; genes in the azoospermia factor (AZF) region of the Y chromosome; and genes associated with male meiosis; and introducing the donor SSCs into a reproductive organ of the genetically-modified, sterile male recipient animal that produces donor-derived, fertilization-competent, haploid male gametes; optionally collecting the donor-derived, fertilization-competent, haploid male gametes.

The independent claims cover generating donor-derived fertilization-competent haploid male gametes by introducing donor SSCs into recipient reproductive organs configured either as sterile hybrid recipients, as genetically-modified recipients with detectable biomarker labeling for distinguishing native versus donor-derived gametes, or as sterile genetically-modified recipients with an intact spermatogenic compartment but blocked spermatogenesis through specified gene deletions or inactivating mutations.

Stated Advantages

Produces donor-derived, fertilization-competent, haploid male gametes.

Allows donor-derived gametes to be collected without the biomarker label and enables distinguishing native from donor-derived male gametes based on the detectable biomarker label.

Documented Applications

Generating fertilization-competent haploid male gametes (sperm) from donor spermatogonial stem cells using sterile hybrid or genetically-modified male recipient animals.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.